Madhusmita Misra, M.D., MPH

Pediatric Endocrinologist

Division Chief, Pediatric Endocrinology

Fritz Bradley Talbot and Nathan Bill Talbot Professor of Pediatrics, Harvard Medical School

Dr. Misra is the Fritz Bradley Talbot and Nathan Bill Talbot Professor of Pediatrics at Harvard Medical School, Chief of the Division of Pediatric Endocrinology at Mass General Hospital for Children, Director of the Pediatric Endocrine-Sports Endocrine-Neuroendocrine Laboratory, and Associate Director of the Harvard Catalyst Clinical Research Center at Massachusetts General Hospital (MGH). Dr. Misra completed her fellowship in Pediatric Endocrinology at Mass General Hospital for Children and Masters in Public Health at the Harvard School of Public Health. She has chaired the Drugs and Therapeutics Committee, the Steering Committee for the Fellow Spring Retreat, and the Research Affairs Council of the Pediatric Endocrine Society (PES). She is currently a Director of the PES (and President Elect starting May 2019), and on the Subboard of Endocrinology for the ABP. Dr. Misra has received the John Haddad Young Investigator Award (AIMM-ASBMR), the Janet W. McArthur Award (Women in Endocrinology), the Claflin Distinguished Scholar Award (MGH) and the Rita M. Kelley, MD, Fellowship (MGH). She is an ex-NIH study section member.

Dr. Misra specializes in neuroendocrinology and bone disorders. She is internationally known for her work on neuroendocrine, metabolic and bone complications of disorders that span the nutritional spectrum from anorexia nervosa to obesity, as well as autism spectrum disorders, and her work has led to major strides in the clinical management of these conditions. Given her work on reproductive and bone dysfunction in the female athlete, she has been identified as an expert on endocrine issues in athletes by the Female Athlete Triad Coalition. Dr. Misra has a special clinical interest in pituitary disorders, and her panel includes children with some of the most complex pituitary tumors. She is associated with the multidisciplinary Neuroendocrine Clinical Center at MGH, and is often asked to provide second opinions on complex pituitary cases. In addition, Dr. Misra sees children with growth and puberty disorders, reproductive, adrenal and thyroid disorders, and children with diabetes.

Read more about Dr. Misra's work: https://www.aneresearch.com/

Publications

Misra M, Katzman DK, Miller KK, Mendes N, Snelgrove D, Russell M, Goldstein MA, Ebrahimi S, Clauss L, Weigel T, Mickley D, Schoenfeld D, Herzog DB, Klibanski A. Physiologic Estrogen Replacement Increases Bone Density in Adolescent Girls with Anorexia Nervosa. J Bone Miner Res 2011;26(10):2430-8. PMID: 21698665

​Misra M, Katzman DK, Estella NM, Eddy K, Miller KK, Klibanski A. Impact of Estrogen Replacement Therapy on Anxiety Symptoms, Body Shape Perception and Eating Attitudes in Adolescent Girls with Anorexia Nervosa. J Clin Psychiatr 2013;74(8):e765-71. PMID: 24021517

Baskaran C, Cunningham C, Plessow P, Singhal V, Woolley R, Ackerman KE, Slattery M, Lee H, Lawson EA, Eddy K, Misra M. Estrogen Replacement Improves Verbal Memory and Executive Control in Oligo-amenorrheic Athletes in a Randomized Controlled Trial. J Clin Psychiatry. 2017 May;78(5):e490-e497. PMID: 28297591

Ackerman KE, Singhal V, Baskaran C, Slattery M, Campoverde Reyes K, Toth A, Eddy KT, Bouxsein ML, Lee H, Klibanski A, Misra M. Oestrogen Replacement Improves Bone Mineral Density in Oligo-amenorrheic Athletes: A Randomized Clinical Trial. Br J Sports Med 2018. In Press PMID: 30301734

Plessow F, Singhal V, Toth A, Micali N, Eddy KT, Misra M. Estrogen Administration Improves the Trajectory of Eating Disorder Pathology in Oligo-Amenorrheic Athletes: A Randomized Trial. Psychoneuroendocrinol 2018. In Press. PMID: 30639922

JH